Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

BACKGROUND: The importance of COVID-19 vaccination for patients on immunosuppressive (IS) medication has increased due to the high risk of severe disease or mortality. Different vaccines have varying efficacy rates against symptomatic COVID-19, ranging from 46.8% to 95%. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosan, Fulya, Demirel, Ozlem Unay, Yalcin, Demet, Sonkaya, Muhammed Mert, Uluisik, Isilsu Ezgi, Cecen, Olida, Furuncuoglu, Yavuz, Celikmen, Deniz Maktav, Kara, Osman, Ceylan, Erkan, Avsar, Timucin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355083/
https://www.ncbi.nlm.nih.gov/pubmed/37468956
http://dx.doi.org/10.1186/s41927-023-00342-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355083/
https://www.ncbi.nlm.nih.gov/pubmed/37468956
http://dx.doi.org/10.1186/s41927-023-00342-x

Ejemplares similares